Literature DB >> 29967542

Mechanism of parkin activation by phosphorylation.

Véronique Sauvé1,2, George Sung1,2, Naoto Soya2,3, Guennadi Kozlov1,2, Nina Blaimschein1,2, Lis Schwartz Miotto1,2, Jean-François Trempe4,5, Gergely L Lukacs2,3, Kalle Gehring6,7.   

Abstract

Mutations in the ubiquitin ligase parkin are responsible for a familial form of Parkinson's disease. Parkin and the PINK1 kinase regulate a quality-control system for mitochondria. PINK1 phosphorylates ubiquitin on the outer membrane of damaged mitochondria, thus leading to recruitment and activation of parkin via phosphorylation of its ubiquitin-like (Ubl) domain. Here, we describe the mechanism of parkin activation by phosphorylation. The crystal structure of phosphorylated Bactrocera dorsalis (oriental fruit fly) parkin in complex with phosphorylated ubiquitin and an E2 ubiquitin-conjugating enzyme reveals that the key activating step is movement of the Ubl domain and release of the catalytic RING2 domain. Hydrogen/deuterium exchange and NMR experiments with the various intermediates in the activation pathway confirm and extend the interpretation of the crystal structure to mammalian parkin. Our results rationalize previously unexplained Parkinson's disease mutations and the presence of internal linkers that allow large domain movements in parkin.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29967542     DOI: 10.1038/s41594-018-0088-7

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN: 1545-9985            Impact factor:   15.369


  43 in total

1.  Parkin inhibits BAK and BAX apoptotic function by distinct mechanisms during mitophagy.

Authors:  Jonathan P Bernardini; Jason M Brouwer; Iris Kl Tan; Jarrod J Sandow; Shuai Huang; Che A Stafford; Aleksandra Bankovacki; Christopher D Riffkin; Ahmad Z Wardak; Peter E Czabotar; Michael Lazarou; Grant Dewson
Journal:  EMBO J       Date:  2018-12-20       Impact factor: 11.598

2.  The landscape of Parkin variants reveals pathogenic mechanisms and therapeutic targets in Parkinson's disease.

Authors:  Wei Yi; Emma J MacDougall; Matthew Y Tang; Andrea I Krahn; Ziv Gan-Or; Jean-François Trempe; Edward A Fon
Journal:  Hum Mol Genet       Date:  2019-09-01       Impact factor: 6.150

Review 3.  Mechanisms of PINK1, ubiquitin and Parkin interactions in mitochondrial quality control and beyond.

Authors:  Andrew N Bayne; Jean-François Trempe
Journal:  Cell Mol Life Sci       Date:  2019-06-28       Impact factor: 9.261

4.  The multifaceted regulation of mitophagy by endogenous metabolites.

Authors:  Ting Zhang; Qian Liu; Weihua Gao; Sheikh Arslan Sehgal; Hao Wu
Journal:  Autophagy       Date:  2021-09-29       Impact factor: 13.391

5.  Cullin-independent recognition of HHARI substrates by a dynamic RBR catalytic domain.

Authors:  Katherine H Reiter; Alex Zelter; Maria K Janowska; Michael Riffle; Nicholas Shulman; Brendan X MacLean; Kaipo Tamura; Matthew C Chambers; Michael J MacCoss; Trisha N Davis; Miklos Guttman; Peter S Brzovic; Rachel E Klevit
Journal:  Structure       Date:  2022-06-17       Impact factor: 5.871

6.  Empirical Bayes functional models for hydrogen deuterium exchange mass spectrometry.

Authors:  Oliver M Crook; Chun-Wa Chung; Charlotte M Deane
Journal:  Commun Biol       Date:  2022-06-15

7.  Site-Specific Detection and Characterization of Ubiquitin Carbamylation.

Authors:  Westley Pawloski; Teppei Komiyama; Christos Kougentakis; Ananya Majumdar; David Fushman
Journal:  Biochemistry       Date:  2022-04-05       Impact factor: 3.321

8.  Quantitative Middle-Down MS Analysis of Parkin-Mediated Ubiquitin Chain Assembly.

Authors:  Kirandeep K Deol; Stephen J Eyles; Eric R Strieter
Journal:  J Am Soc Mass Spectrom       Date:  2020-04-28       Impact factor: 3.109

Review 9.  Decoding the messaging of the ubiquitin system using chemical and protein probes.

Authors:  Lukas T Henneberg; Brenda A Schulman
Journal:  Cell Chem Biol       Date:  2021-04-07       Impact factor: 8.116

Review 10.  The ubiquitin proteoform problem.

Authors:  Kirandeep K Deol; Eric R Strieter
Journal:  Curr Opin Chem Biol       Date:  2021-04-01       Impact factor: 8.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.